Head of West Coast Biotechnology Investment Banking
Andrew Gitkin is a managing director and head of West Coast biotechnology investment banking at Piper Jaffray. Andrew has 25+ years of healthcare investment experience, most recently at Moelis & Company, where he was a senior vice president in the life sciences investment banking group. Andrew was previously with Saddle Point Asset Management where he was a managing member and healthcare portfolio manager. Prior to that, he was a vice president at Tavistock Life Sciences where he was responsible for managing a healthcare-focused investment partnership. As a senior healthcare analyst in equity research at UBS and SalomonSmithBarney he was awarded rankings by Institutional Investor and Greenwich Associates. Andrew holds a bachelor’s degree in business administration from the Goizueta School of Business at Emory University.